Qingzhou Guan

Henan University of Traditional Chinese Medicine

H指数:20

被引数:1,020

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effective-Component Compatibility of Bufei Yishen Formula III Improves Chronic Obstructive Pulmonary Disease by Inhibiting Inflammatory Responses Through Blocking PTX3 Activation

补肺益肾方III有效成分配伍通过阻断PTX3激活抑制炎症反应改善慢性阻塞性肺疾病

Journal of Inflammation Research

IF4.1

2026-08-060

OAAI

Mechanism of effective-component compatibility of Bufei Yishen formula III in COPD and identification of hub genes

补肺益肾方III有效成分配伍机制在COPD中的作用及核心基因的鉴定

Phytomedicine

IF8.3

2026-07-010

PRE

Screening biomarkers for diagnosis of COPD by multiplex-high-resolution mass spectrometry based pseudotargeted lipidomics

基于多反应监测-高分辨质谱的伪靶向脂质组学筛选COPD诊断生物标志物

Journal of Chromatography B

IF0

2025-10-020

PRE

Exploring the Intervention Mechanism of Effective-Component Combination of Bufei Yishen Formula III for Airway Epithelial Barrier Injury: A miRNA-mRNA Regulatory Network Analysis

探讨补肺益肾方III有效成分组合干预气道上皮屏障损伤的作用机制：miRNA-mRNA调控网络分析

Journal of Inflammation Research

IF4.1

2025-09-040

Identification of Potential Hub Genes for Acupuncture in Treatment with Chronic Obstructive Pulmonary Disease via Integrated Bioinformatics Analysis

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Mechanism underlying the therapeutic effects of effective component compatibility of Bufei Yishen formula III combined with exercise rehabilitation on chronic obstructive pulmonary disease

ANNALS OF MEDICINE

IF4.3

2024-09-140

OAAI

Identification of idiopathic pulmonary fibrosis hub genes and exploration of the mechanisms of action of Jinshui Huanxian formula

特发性肺纤维化枢纽基因的鉴定及金水环纤方的作用机制探讨

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-05-010

OAAI

Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway

CHINESE MEDICINE

IF5.7

2024-02-282

OAAI

Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination

PHYTOMEDICINE

IF8.3

2023-09-016

OAAI

Identification of cancer risk assessment signature in patients with chronic obstructive pulmonary disease and exploration of the potential key genes

ANNALS OF MEDICINE

IF4.3

2022-08-204

OAAI

Biased Influences of Low Tumor Purity on Mutation Detection in Cancer

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2020-12-2310

OAAI

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2020-12-045

OAAI

Qualitative diagnostic signature for pancreatic ductal adenocarcinoma based on the within-sample relative expression orderings

基于样本内相对表达排序的胰腺导管腺癌定性诊断特征

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2020-11-272

PREAI

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2020-03-255

OAAI

A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I-III Bladder Cancer Patients After Surgical Resection

FRONTIERS IN ONCOLOGY

IF3.3

2019-07-104

OAAI

A robust qualitative transcriptional signature for the correct pathological diagnosis of gastric cancer

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2019-02-2812

OAAI

Identification and characterization of genes with absolute mRNA abundances changes in tumor cells with varied transcriptome sizes

转录组大小不同的肿瘤细胞中具有绝对mRNA丰度变化的基因的鉴定和表征

BMC GENOMICS

IF3.7

2019-02-132

OAAI

Identification of genes with universally upregulated or downregulated expressions in colorectal cancer

鉴定结直肠癌中普遍上调或下调表达的基因

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2018-12-1117

PREAI

A qualitative signature for predicting pathological response to neoadjuvant chemoradiation in locally advanced rectal cancers

RADIOTHERAPY AND ONCOLOGY

IF5.3

2018-10-0118

PREAI

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings

LIVER INTERNATIONAL

IF5.2

2018-05-1229

OAAI

Qingzhou Guan

个人简介

教育背景

工作经历

荣誉奖项

研究方向